News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,769 Results
Type
Article (14274)
Company Profile (281)
Press Release (254214)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79555)
Career Advice (153)
Deals (13233)
Drug Delivery (35)
Drug Development (50470)
Employer Resources (31)
FDA (5729)
Job Trends (5138)
News (144471)
Policy (10035)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21684)
ALS (68)
Alzheimer's disease (850)
Antibody-drug conjugate (ADC) (108)
Approvals (5754)
Artificial intelligence (132)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (161)
Cancer (1515)
Cardiovascular disease (120)
Career advice (134)
Career pathing (2)
CAR-T (121)
Cell therapy (337)
Cervical cancer (9)
Clinical research (41158)
Collaboration (557)
Compensation (275)
Complete response letters (13)
COVID-19 (1036)
CRISPR (44)
C-suite (171)
Cystic fibrosis (77)
Data (1592)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (30069)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48763)
Executive appointments (471)
FDA (6493)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (509)
Gene editing (102)
Generative AI (10)
Gene therapy (260)
GLP-1 (370)
Government (1085)
Grass and pollen (2)
Guidances (66)
Healthcare (6596)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (96)
Indications (20)
Infectious disease (1102)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7280)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (214)
Leadership (3)
Legal (1386)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (147)
MASH (59)
Medical device (2602)
Medtech (2603)
Mergers & acquisitions (6291)
Metabolic disorders (402)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (71)
Neuropsychiatric disorders (25)
Neuroscience (1269)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (22)
Obesity (197)
Opinion (102)
Ovarian cancer (66)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (121)
Partnered (8)
Patents (135)
Patient recruitment (82)
Peanut (35)
People (25683)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14538)
Phase II (19152)
Phase III (12096)
Pipeline (915)
Policy (48)
Postmarket research (852)
Preclinical (6156)
Press Release (30)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (296)
Real estate (1419)
Recruiting (12)
Regulatory (8677)
Reports (16)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (62)
Series A (99)
Series B (66)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1976)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Last 7 days (555)
Last 30 days (1702)
Last 365 days (19249)
2025 (6915)
2024 (20551)
2023 (22416)
2022 (26822)
2021 (27806)
2020 (23359)
2019 (16225)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14350)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7430)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (17345)
Australia (2941)
California (4036)
Canada (1170)
China (372)
Colorado (152)
Connecticut (154)
Delaware (109)
Europe (37327)
Florida (491)
Georgia (121)
Idaho (16)
Illinois (238)
India (10)
Indiana (94)
Iowa (2)
Japan (78)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (492)
Massachusetts (3209)
Michigan (72)
Minnesota (150)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1001)
New Mexico (12)
New York (1081)
North Carolina (567)
North Dakota (5)
Northern California (1796)
Ohio (114)
Oklahoma (9)
Oregon (21)
Pennsylvania (762)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1553)
Tennessee (25)
Texas (468)
United States (13782)
Utah (56)
Virginia (83)
Washington D.C. (31)
Washington State (359)
Wisconsin (16)
268,769 Results for "arcturus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
April 23, 2025
·
1 min read
Press Releases
Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
March 5, 2025
·
1 min read
Press Releases
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
March 6, 2025
·
15 min read
Press Releases
Arcturus Therapeutics to Present at Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
February 4, 2025
·
3 min read
Press Releases
Arcturus Therapeutics to Attend Upcoming Investor Conferences
November 26, 2024
·
1 min read
Press Releases
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
April 10, 2025
·
5 min read
Business
Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors
Arcturus Therapeutics Holdings Inc. today announced the appointment of a new independent director, Moncef Slaoui, Ph.D., to the Company’s Board of Directors.
June 20, 2024
·
5 min read
Biotech Beach
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
Arcturus Therapeutics Holdings Inc. announced Arcturus will be presenting Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032, an inhaled investigational mRNA therapeutic to treat CF, at the 47th European Cystic Fibrosis Conference on June 7, 2024.
May 28, 2024
·
5 min read
Press Releases
Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025
February 24, 2025
·
1 min read
1 of 26,877
Next
